Bambuterol: Difference between revisions

Jump to navigation Jump to search
m (Protected "Bambuterol": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 27: Line 27:
{{CMG}}
{{CMG}}


{{Editor Join}}
 





Revision as of 22:44, 8 August 2012

Bambuterol
Clinical data
Pregnancy
category
  • Unknown
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability20%
MetabolismHepatic, extensive
Further metabolized to terbutaline by plasma cholinesterase
Elimination half-life13 hours (bambuterol)
21 hours (terbutaline)
ExcretionRenal
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC18H29N3O5
Molar mass367.44 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]



Bambuterol (INN, marketed by AstraZeneca under the trade names Bambec and Oxeol) is a long acting beta-adrenoceptor agonist used in the treatment of asthma. It is a prodrug of terbutaline.

Template:Asthma and copd rx

Template:WikiDoc Sources